Cargando…

Application of Auxiliary VerifyNow Point-of-Care Assays to Assess the Pharmacodynamics of RUC-4, a Novel αIIbβ3 Receptor Antagonist

Introduction Prehospital therapy of ST-elevation myocardial infarction (STEMI) with αIIbβ3 antagonists improves clinical outcomes, but they are difficult to use in prehospital settings. RUC-4 is a novel αIIbβ3 antagonist being developed for prehospital therapy of STEMI that rapidly achieves high-gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bentur, Ohad S., Li, Jihong, Jiang, Caroline S., Martin, Linda H., Kereiakes, Dean J., Coller, Barry S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478527/ https://www.ncbi.nlm.nih.gov/pubmed/34604694 http://dx.doi.org/10.1055/s-0041-1732343

Ejemplares similares

First Human Use of RUC‐4: A Nonactivating Second‐Generation Small‐Molecule Platelet Glycoprotein IIb/IIIa (Integrin αIIbβ3) Inhibitor Designed for Subcutaneous Point‐of‐Care Treatment of ST‐Segment–Elevation Myocardial Infarction
por: Kereiakes, Dean J., et al.
Publicado: (2020)

Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets
por: Vootukuri, Spandana, et al.
Publicado: (2019)

Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor
por: Angiolillo, Dominick J., et al.
Publicado: (2021)

Periprocedural Variability of Platelet Functions in Carotid Artery Stenting: An Analysis Using VerifyNow
por: Yoshimura, Masataka, et al.
Publicado: (2021)

Comparison of VerifyNow, thromboelastography, and PL-12 in patients with minor ischemic stroke or transient ischemic attack
por: Ma, Lin, et al.
Publicado: (2021)

Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry
por: Kim, Yun Gi, et al.
Publicado: (2014)

Clopidogrel non-responsiveness in patients undergoing percutaneous coronary intervention using the VerifyNow test: frequency and predictors
por: Yaseen, Israa Fadhil, et al.
Publicado: (2019)

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
por: Mshelbwala, Fakilahyel S, et al.
Publicado: (2020)

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing
por: Willemsen, Laura M., et al.
Publicado: (2021)

Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020)

Performance comparison of aspirin assay between Anysis and VerifyNow: Assessment of therapeutic platelet inhibition in patients with cardiac diseases
por: Piao, Jinxiang, et al.
Publicado: (2021)

The optimal threshold of high post-treatment platelet reactivity could be defined by a point-of-care VerifyNow P2Y12 assay
por: Jeong, Young-Hoon, et al.
Publicado: (2008)

Point of Care Tests VerifyNow P2Y12 and INNOVANCE PFA P2Y Compared to Light Transmittance Aggregometry After Fibrinolysis
por: Roule, Vincent, et al.
Publicado: (2018)

Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking
por: Buitrago, Lorena, et al.
Publicado: (2021)

Effects of Vonoprazan on the Antiplatelet Function of Prasugrel Assessed by the VerifyNow P2Y(12) Assay in Patients With Coronary Artery Disease
por: Koga, Seiji, et al.
Publicado: (2020)

Change of Platelet Reactivity to Antiplatelet Therapy after Stenting Procedure for Cerebral Artery Stenosis: VerifyNow Antiplatelet Assay before and after Stenting
por: Lee, Deok Hee, et al.
Publicado: (2012)

3409 The Power of Phenotypic Extremes in Detecting Novel Genetic Modifiers of Hemophilia
por: Bentur, Ohad Shimshon, et al.
Publicado: (2019)

RUCS: rapid identification of PCR primers for unique core sequences
por: Thomsen, Martin Christen Frølund, et al.
Publicado: (2017)

Comparison of VerifyNow-P2Y(12 )test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?
por: Godino, Cosmo, et al.
Publicado: (2009)

Swing-Out of the β3 Hybrid Domain Is Required for αIIbβ3 Priming and Normal Cytoskeletal Reorganization, but Not Adhesion to Immobilized Fibrinogen
por: Cheng, Ming, et al.
Publicado: (2013)

RUC-Net: A Residual-Unet-Based Convolutional Neural Network for Pixel-Level Pavement Crack Segmentation
por: Yu, Gui, et al.
Publicado: (2022)

The fixed point theorem of Brouwer and verified inclusions
por: Rex, G
Publicado: (1999)

Phase 1 Randomized Placebo-Controlled Study in Healthy Adult Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate – A Potential Treatment for COVID-19
por: Bentur, Ohad, et al.
Publicado: (2021)

COPD in exclusive narghile smokers: Some points to verify
por: Saad, Helmi Ben
Publicado: (2017)

Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?
por: Iannetta, Loredana, et al.
Publicado: (2013)

Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases
por: Abdeladim, Salma, et al.
Publicado: (2021)

Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
por: Sidharta, P. N., et al.
Publicado: (2015)

Pharmacodynamics of the Glutamate Receptor Antagonists in the Rat Barrel Cortex
por: Vinokurova, Daria, et al.
Publicado: (2018)

CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic
por: MacArthur, Robert B., et al.
Publicado: (2021)

Keypunching and verifying
por: Farina, Mario V.
Publicado: (1973)

To trust? Or to verify?
por: Harendza, Sigrid
Publicado: (2018)

Verifiable biology
por: Konur, Savas, et al.
Publicado: (2023)

Computer arithmetic and formal proofs: verifying floating-point algorithms with the Coq system
por: Boldo, Sylvie, et al.
Publicado: (2017)

Authors’ response to letter—COPD in exclusive narghile smokers: Some points to verify
por: Bahtouee, Mehrzad, et al.
Publicado: (2017)

Phosphate reabsorption in the kidney: NaPi-IIb or not IIb
por: Burns, David, et al.
Publicado: (2020)

Verifiability on the run: an experimental study on the verifiability approach to malingered symptoms
por: Boskovic, Irena, et al.
Publicado: (2018)

Verifynow P2Y(12) PRU-Guided Modification of Clopidogrel for Prevention of Recurrent Ischemic Stroke: A Real-World Prospective Cohort Study
por: Zhang, Yuanjin, et al.
Publicado: (2022)

An Effective Method of Detecting Characteristic Points of Impedance Cardiogram Verified in the Clinical Pilot Study
por: Karpiel, Ilona, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
por: Namour, Florence, et al.
Publicado: (2015)

Debate: Unstable angina - When should we intervene?
por: Kereiakes, Dean J
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_813c20olc93pt29t85altoh06o